Waldenström's macroglobulinemia diagnostic study of choice: Difference between revisions
No edit summary |
|||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}} {{RAK}} | {{CMG}} {{AE}} {{RAK}} | ||
== Overview== | |||
The diagnosis of Waldenström macroglobulinemia is based on bone marrow biopsy and serum protein analysis. | |||
== Diagnostic study of choice == | == Diagnostic study of choice == | ||
*There is no single diagnostic study of choice for the diagnosis of Waldenström macroglobulinemia, but WM can be diagnosed based on a bone marrow biopsy and an analysis of serum protein components. | *There is no single diagnostic study of choice for the diagnosis of Waldenström macroglobulinemia, but WM can be diagnosed based on a bone marrow biopsy and an analysis of serum protein components.<ref name="pmid15735132">{{cite journal| author=Dimopoulos MA, Kyle RA, Anagnostopoulos A, Treon SP| title=Diagnosis and management of Waldenstrom's macroglobulinemia. | journal=J Clin Oncol | year= 2005 | volume= 23 | issue= 7 | pages= 1564-77 | pmid=15735132 | doi=10.1200/JCO.2005.03.144 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15735132 }} </ref>26980727<ref name="pmid26980727">{{cite journal| author=Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R et al.| title=The 2016 revision of the World Health Organization classification of lymphoid neoplasms. | journal=Blood | year= 2016 | volume= 127 | issue= 20 | pages= 2375-90 | pmid=26980727 | doi=10.1182/blood-2016-01-643569 | pmc=4874220 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26980727 }} </ref> | ||
==References== | ==References== | ||
Revision as of 23:01, 30 October 2018
|
Waldenström's macroglobulinemia Microchapters |
|
Differentiating Waldenström's macroglobulinemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Waldenström's macroglobulinemia diagnostic study of choice On the Web |
|
American Roentgen Ray Society Images of Waldenström's macroglobulinemia diagnostic study of choice |
|
FDA on Waldenström's macroglobulinemia diagnostic study of choice |
|
CDC on Waldenström's macroglobulinemia diagnostic study of choice |
|
Waldenström's macroglobulinemia diagnostic study of choice in the news |
|
Blogs on Waldenström's macroglobulinemia diagnostic study of choice |
|
Directions to Hospitals Treating Waldenström's macroglobulinemia |
|
Risk calculators and risk factors for Waldenström's macroglobulinemia diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Roukoz A. Karam, M.D.[2]
Overview
The diagnosis of Waldenström macroglobulinemia is based on bone marrow biopsy and serum protein analysis.
Diagnostic study of choice
- There is no single diagnostic study of choice for the diagnosis of Waldenström macroglobulinemia, but WM can be diagnosed based on a bone marrow biopsy and an analysis of serum protein components.[1]26980727[2]
References
- ↑ Dimopoulos MA, Kyle RA, Anagnostopoulos A, Treon SP (2005). "Diagnosis and management of Waldenstrom's macroglobulinemia". J Clin Oncol. 23 (7): 1564–77. doi:10.1200/JCO.2005.03.144. PMID 15735132.
- ↑ Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R; et al. (2016). "The 2016 revision of the World Health Organization classification of lymphoid neoplasms". Blood. 127 (20): 2375–90. doi:10.1182/blood-2016-01-643569. PMC 4874220. PMID 26980727.